Anders Poulsen

According to our database, Anders Poulsen authored at least 6 papers between 2002 and 2015.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2015

Pharmacophore Model for Wnt/Porcupine Inhibitors and Its Use in Drug Design.

Anders Poulsen, Soo Yei Ho, Weiling Wang, Jenefer Alam, Duraiswamy A. Jeyaraj, Shi Hua Ang, Eldwin Sum Wai Tan, Grace Ruiting Lin, Vivien Wei Wen Cheong, Zhiyuan Ke, May Ann Lee, Thomas H. Keller

J. Chem. Inf. Model., 2015

2014

Structure and Ligand-Based Design of mTOR and PI3-Kinase Inhibitors Leading to the Clinical Candidates VS-5584 (SB2343) and SB2602.

Anders Poulsen, Harish Nagaraj, Angeline Lee, Stéphanie Blanchard, Chang Kai Soh, Dizhong Chen, Haishan Wang, Stefan Hart, Kee Chuan Goh, Brian Dymock, Meredith Williams

J. Chem. Inf. Model., 2014

2012

Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3).

Anders Poulsen, Anthony William, Stéphanie Blanchard, Angeline Lee, Harish Nagaraj, Haishan Wang, Eeling Teo, Evelyn Tan, Kee Chuan Goh, Brian Dymock

J. Comput. Aided Mol. Des., 2012

2008

Structure-based design of Aurora A & B inhibitors.

Anders Poulsen, Anthony William, Angeline Lee, Stéphanie Blanchard, Eeling Teo, Weiping Deng, Noah Tu, Evelyn Tan, Eric Sun, Kay Lin Goh, Wai Chung Ong, Chee Pang Ng, Kee Chuan Goh, Zahid Bonday

J. Comput. Aided Mol. Des., 2008

2003

Pharmacophore and receptor models for neurokinin receptors.

Anders Poulsen, Berith Bjørnholm, Klaus Gundertofte, Irina D. Pogozheva, Tommy Liljefors

J. Comput. Aided Mol. Des., 2003

2002

A pharmacophore model for NK2 antagonist comprising compounds from several structurally diverse classes.

Anders Poulsen, Tommy Liljefors, Klaus Gundertofte, Berith Bjørnholm

J. Comput. Aided Mol. Des., 2002